Loading...
Omalizumab as add‐on therapy in a patient with severe asthma and OSA
Obstructive sleep apnoea (OSA) syndrome, the most frequent sleep‐disordered breathing, is a comorbidity of asthma, whose prevalence covers about 49.5% of asthmatic adult patients. A 61‐year‐old female patient, affected by severe allergic asthma and obesity, started treatment with omalizumab and unde...
Na minha lista:
| Udgivet i: | Respirol Case Rep |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006716/ https://ncbi.nlm.nih.gov/pubmed/32055401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.518 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|